ROSEN, A RANKED AND LEADING FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
January 16, 2024 17:46 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, Microvast, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
January 15, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
January 12, 2024 16:37 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
January 11, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 10, 2024 12:08 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
January 10, 2024 10:00 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
January 08, 2024 18:31 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Eagle...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
January 07, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 05, 2024 12:06 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
January 05, 2024 09:45 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...